Therapeutic Asset Ratings

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Cytarabine Breast Cancer	Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.	P4	BB (67)
Cytarabine Neoplastic Meningitis	Fudan University	P4	BB (67)
Dalteparin Venous Thromboembolism	Beijing Friendship Hospital	P4	BB (67)
Dapagliflozin Diabetes Mellitus	Erbil Polytechnic University	P4	BB (67)
Darolutamide Prostate Cancer	University of Chicago	P4	BB (67)
Deferasirox Sickle Cell Disease	Inova Health Care Services	P4	BB (67)
Dexasone Hypersensitivity Reaction Disease	Shanghai Pulmonary Hospital, Shanghai, China	P4	BB (67)
Dinitrogen Monoxide Major Depressive Disorder	University of Chicago	P4	BB (67)
Elranatamab Plasma Cell Myeloma	Anne Louise Tølbøll Sørensen	P4	BB (67)
Empagliflozin Metabolic Dysfunction-Associated Steatohepatitis	Badr University	P4	BB (67)
Etoposide Extranodal Nasal NK/T Cell Lymphoma	Tarapeutics Science Inc.	P4	BB (67)
Etoposide Angioimmunoblastic T-Cell Lymphoma	Eric Jacobsen, MD	P4	BB (67)
Etoposide Hemophagocytic Syndrome	Beijing Tongren Hospital	P4	BB (67)
Etoposide Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma	Alliance for Clinical Trials in Oncology	P4	BB (67)
Etoposide Peripheral T-Cell Lymphoma, Not Otherwise Specified	Tarapeutics Science Inc.	P4	BB (67)
Etoposide Primary Central Nervous System Lymphoma	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	P4	BB (67)
Fluorouracilum Breast Neoplasm	Rutgers, The State University of New Jersey	P4	BB (67)
Furosemide Cirrhosis Of Liver	Stacy Johnson	P4	BB (67)
Gabapentin Chronic Pain Syndrome	Federico II University	P4	BB (67)
Glatiramer Multiple Sclerosis	Centre Hospitalier Universitaire de Nice	P4	BB (67)
Glutamine Sickle Cell Disease	Ain Shams University	P4	BB (67)
Golodirsen Duchenne Muscular Dystrophy	Rare Disease Research, LLC	P4	BB (67)
Idarubicin Acute Lymphoblastic Leukemia	Xianmin Song, MD	P4	BB (67)
Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,461-Alanine,462-Alanine,556-Glycine,581-Cysteine,593-Tryptophan), Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 Vh-Ch1 Fragment) Fusion Protein With Peptide (Synthetic 10-Amino Acid Linker) Fusion Protein With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Heavy Chain Vl(.Lambda.)-Ch1-Ch2-Ch3), (222->219''')-Disulfide With Immunoglobulin Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)) And (447->232'')-Disulfide With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Light Chain Vh-Cl(.Kappa.)), (453->228'), (456->231'), (581->351')-Tris(Disulfide) With Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,236-Alanine,237-Alanine,331-Glycine,351-Cysteine,368-Serine,370-Alanine,409-Valine) Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Gamma.1-Chain) Disulfide With Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine) B-Cell Non-Hodgkin Lymphoma	Brown University	P4	BB (67)
Immunoglobulin G1, Anti-(Human Epidermal Growth Factor Receptor Her2) (Human-Mus Musculus Monoclonal Shr-1805 ?1-Chain), Complex With Human-Mus Musculus Monoclonal Shr-1805 ?-Chain, Dimer, Thioether With N-[6-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-1-Oxohexyl]Glycylglycyl-L-Phenylalanyl-N-[[(1R)-1-Cyclopropyl-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-2-Oxoethoxy]Methyl]Glycinamide Breast Cancer	Fudan University	P4	BB (67)

Showing 1601 to 1625 of 42,301 assets

PreviousPage 65 of 1693Next